Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 78

Similar articles for PubMed (Select 8855240)

1.

Conformational change and enhanced stabilization of the vitamin D receptor by the 1,25-dihydroxyvitamin D3 analog KH1060.

van den Bemd GC, Pols HA, Birkenhäger JC, van Leeuwen JP.

Proc Natl Acad Sci U S A. 1996 Oct 1;93(20):10685-90.

2.

Contribution of several metabolites of the vitamin D analog 20-epi-22-oxa-24a,26a,27a-tri-homo-1,25-(OH)(2) vitamin D(3) (KH 1060) to the overall biological activity of KH1060 by a shared mechanism of action.

van den Bemd GC, Dilworth FJ, Makin HL, Prahl JM, Deluca HF, Jones G, Pols HA, van Leeuwen JP.

Biochem Pharmacol. 2000 Mar 15;59(6):621-7.

PMID:
10677578
3.
4.

Modulation of vitamin D receptor and estrogen receptor by 1,25(OH)2-vitamin D3 in T-47D human breast cancer cells.

Davoodi F, Brenner RV, Evans SR, Schumaker LM, Shabahang M, Nauta RJ, Buras RR.

J Steroid Biochem Mol Biol. 1995 Aug;54(3-4):147-53.

PMID:
7662588
5.

Response element and coactivator-mediated conformational change of the vitamin D(3) receptor permits sensitive interaction with agonists.

Herdick M, Bury Y, Quack M, Uskokovic MR, Polly P, Carlberg C.

Mol Pharmacol. 2000 Jun;57(6):1206-17.

8.

2-Methylene-19-nor-(20S)-1,25-dihydroxyvitamin D3 potently stimulates gene-specific DNA binding of the vitamin D receptor in osteoblasts.

Yamamoto H, Shevde NK, Warrier A, Plum LA, DeLuca HF, Pike JW.

J Biol Chem. 2003 Aug 22;278(34):31756-65. Epub 2003 Jun 9.

9.
10.

A central dinucleotide within vitamin D response elements modulates DNA binding and transactivation by the vitamin D receptor in cellular response to natural and synthetic ligands.

van den Bemd GJ, Jhamai M, Staal A, van Wijnen AJ, Lian JB, Stein GS, Pols HA, van Leeuwen JP.

J Biol Chem. 2002 Apr 26;277(17):14539-46. Epub 2002 Feb 7.

11.

A structural basis for the species-specific antagonism of 26,23-lactones on vitamin D signaling.

Peräkylä M, Molnár F, Carlberg C.

Chem Biol. 2004 Aug;11(8):1147-56.

PMID:
15324816
12.

Upregulation of vitamin D receptor levels by 1,25(OH)2 vitamin D3 in cultured human keratinocytes.

Sølvsten H, Svendsen ML, Fogh K, Kragballe K.

Arch Dermatol Res. 1997 May;289(6):367-72.

PMID:
9209684
13.
14.
15.

Carboxylic ester antagonists of 1alpha,25-dihydroxyvitamin D(3) show cell-specific actions.

Herdick M, Steinmeyer A, Carlberg C.

Chem Biol. 2000 Nov;7(11):885-94.

16.

Inhibition of proliferation and induction of apoptosis by 25-hydroxyvitamin D3-3beta-(2)-Bromoacetate, a nontoxic and vitamin D receptor-alkylating analog of 25-hydroxyvitamin D3 in prostate cancer cells.

Swamy N, Chen TC, Peleg S, Dhawan P, Christakos S, Stewart LV, Weigel NL, Mehta RG, Holick MF, Ray R.

Clin Cancer Res. 2004 Dec 1;10(23):8018-27.

17.

Cross-talk between vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling in melanoma cells.

Sertznig P, Dunlop T, Seifert M, Tilgen W, Reichrath J.

Anticancer Res. 2009 Sep;29(9):3647-58.

18.

Evidence that both 1alpha,25-dihydroxyvitamin D3 and 24-hydroxylated D3 enhance human osteoblast differentiation and mineralization.

van Driel M, Koedam M, Buurman CJ, Roelse M, Weyts F, Chiba H, Uitterlinden AG, Pols HA, van Leeuwen JP.

J Cell Biochem. 2006 Oct 15;99(3):922-35.

PMID:
16741965
19.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk